IM Cannabis (IMCC) Cash & Current Investments (2019 - 2026)
IM Cannabis (IMCC) recorded quarterly Cash & Current Investments of $732122.5 in Q1 2026, down 62.56% quarter-over-quarter from $2.0 million in Q4 2025, and up 21.73% on a YoY basis from $601438.9 in Q1 2025.
IM Cannabis (IMCC) Cash & Current Investments (2019 - 2026) Analysis & Trends
IM Cannabis' Cash & Current Investments history runs 8 years deep, the most recent figure standing at $732122.5 for Q1 2026.
- In Q1 2026, Cash & Current Investments rose 21.73% year-over-year to $732122.5; the TTM figure through Mar 2026 stood at $732122.5 (up 21.73% YoY), while the FY2025 annual figure was $2.0 million, up 188.81% from the prior year.
- Cash & Current Investments was $732122.5 for Q1 2026 at IM Cannabis, down from $2.0 million in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $11.0 million in Q1 2022 to a low of $573039.7 in Q2 2025.
- Historically, Cash & Current Investments has averaged $3.0 million across 5 years, with a median of $1.7 million in 2025.
- The sharpest annual moves came in 2022 and 2025: Cash & Current Investments sank 83.66% in 2022, then jumped 194.68% in 2025.
- A 5-year view of Cash & Current Investments shows it stood at $1.8 million in 2022, then retreated by 26.19% to $1.3 million in 2023, then plunged by 50.17% to $663592.2 in 2024, then surged by 194.68% to $2.0 million in 2025, then plunged by 62.56% to $732122.5 in 2026.
- The last three Cash & Current Investments figures came in at $732122.5 (Q1 2026), $2.0 million (Q4 2025), and $1.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 3.74 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 1.94 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 2.15 Bn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 77.77 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 1.32 Bn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 428.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 511.86 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 498.58 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 750.88 Mn |
| 10 | IM Cannabis | 57,090.22 | -728,264.31 | 1.03 Mn | 732,122.51 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 732,122.51 |
| Dec 31, 2025 | 1.96 Mn |
| Sep 30, 2025 | 1.68 Mn |
| Jun 30, 2025 | 573,039.72 |
| Mar 31, 2025 | 601,438.92 |
| Dec 31, 2024 | 663,592.15 |
| Sep 30, 2024 | 1.33 Mn |
| Jun 30, 2024 | 1.33 Mn |
| Mar 31, 2024 | 1.35 Mn |
| Dec 31, 2023 | 1.33 Mn |
| Sep 30, 2023 | 1.83 Mn |
| Jun 30, 2023 | 1.82 Mn |
| Mar 31, 2023 | 1.81 Mn |
| Dec 31, 2022 | 1.80 Mn |
| Sep 30, 2022 | 10.66 Mn |
| Jun 30, 2022 | 10.91 Mn |
| Mar 31, 2022 | 11.00 Mn |
| Dec 31, 2021 | 11.04 Mn |
| Sep 30, 2021 | 7.09 Mn |
| Jun 30, 2021 | 7.26 Mn |